Industry News
-
Trump nixes biologic protections in new trade deal
A new trade pact being negotiated between the U.S., Mexico and Canada has been stripped of provisions that would have protected drugmakers from biosimilar competition for at least a decade.
12/11/2019 -
Correvio might look for buyer after FDA panel shoots down heart drug
Correvio Pharma Corp could hunt for a potential buyer now that its pivotal heart drug is not likely to win FDA approval.
12/11/2019 -
J&J CEO declines appearance at U.S. congressional hearing on talc carcinogens
According to the House of Representatives Subcommittee on Economic and Consumer Policy, Johnson & Johnson CEO Alex Gorsky declined to testify even after over a month of attempts to accommodate the company.
12/10/2019 -
Sanofi, Regeneron restructure 12-year-old partnership
The existing collaboration relating to Dupixent (dupilumab), which recently reached $633 million in global sales, will remain unchanged following the restructuring
12/10/2019 -
Execs face jail time for Samsung Biologics fraud
A court in South Korea has handed out prison sentences for three Samsung executives involved in accounting fraud at the company’s biotech arm.
12/09/2019 -
Merck makes big cancer buy with $2.7B ArQule deal
Another day — another big oncology deal in pharma.
12/09/2019 -
FDA removes hold on pivotal gene therapy trial
Abeona Therapeutics announced that the U.S. FDA has removed its clinical hold on the company’s pivotal Phase 3 clinical trial evaluating gene therapy for the treatment of recessive dystrophic epidermolysis bullosa (RDEB).
12/09/2019 -
Sanofi to acquire Synthorx for $2.5B
Sanofi will acquire clinical-stage biotechnology company, Synthorx, for approximately $2.5 billion.
12/09/2019 -
Pharma in review: trending stories 12/6/19
Most popular Pharma Manufacturing stories from the past seven days.
12/06/2019 -
FDA approves first generics of Novartis blockbuster MS drug
The U.S. FDA has approved three applications for first generics of Gilenya capsules for the treatment of relapsing forms of multiple sclerosis in adults.
12/06/2019 -
Novartis partners with Amazon to boost manufacturing efficiency
Novartis will work with Amazon’s cloud-computing unit, Amazon Web Services, to make the manufacturing and delivery of new medicines more efficient.
12/06/2019 -
EMA asks pharma to test diabetes drugs for NDMA
Common diabetes drugs have become the newest target of an ongoing NDMA scare in pharma.
12/04/2019 -
Merck spars with insurers over $1.3B cyberattack
Merck says that the attack wiped out years of research data, hampered work at facilities and cost the company $1.3 billion in damages.
12/04/2019 -
Biocon and Mylan nab FDA approval for Herceptin biosim
Co-developed by both companies, Ogivri will be used for the treatment of breast and gastric cancer patients.
12/03/2019 -
AstraZeneca sells more Seroquel rights to Cheplapharm for $42 million
Cheplapharm now adds the rights in United States and Canada to its recently acquired ones for Seroquel and Seroquel XR in most European markets and Russia.
12/03/2019 -
FDA denies Lexicon appeal of drug rejection
Lexicon Pharmaceuticals has failed in its efforts to appeal a rejection from the FDA for its diabetes drug, Zynquista.
12/03/2019 -
Astellas to shell out $3 billion in gene therapy takeover
Japan-based Astellas Pharma is dropping nearly $3 billion in cash to scoop up San Francisco’s Audentes Therapeutics.
12/03/2019 -
Samoan government shuts down over measles outbreak
The Samoan government will shut down for two days as part of a series of drastic steps being taken to stop a deadly outbreak of measles.
12/02/2019 -
Lilly opens shared innovation lab
Eli Lilly and Company unveiled its first shared innovation lab, located in South San Francisco, designed to speed the discovery of innovative medicines through collaboration.
12/02/2019 -
Harvard, MIT, hospitals and industry create facility for next-generation med development
They will pool resources to create a new $50 million center for advanced biological innovation and manufacturing in Boston.
11/26/2019